Takuma Kagami
Seirei Hamamatsu General Hospital(JP)
Publications by Year
Research Areas
Helicobacter pylori-related gastroenterology studies, Gastroesophageal reflux and treatments, Gastric Cancer Management and Outcomes, Eosinophilic Esophagitis, Microscopic Colitis
Most-Cited Works
- → Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference toCYP2C19 genotype(2016)249 cited
- → Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori(2019)123 cited
- → Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)(2020)61 cited
- → High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication(2018)60 cited
- → The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy(2020)35 cited
- → High Helicobacter pylori cure rate with sitafloxacin‐based triple therapy(2015)35 cited
- → Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype(2017)33 cited
- → Eradication of <i>H. pylori</i> Infection in Patients Allergic to Penicillin Using Triple Therapy with a PPI, Metronidazole and Sitafloxacin(2014)30 cited
- → Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese(2014)28 cited
- → High expression level of CD44v8-10 in cancer stem-like cells is associated with poor prognosis in esophageal squamous cell carcinoma patients treated with chemoradiotherapy(2018)27 cited